Antiviral Drug Development: Overcoming Challenges to the Current Model
PharmaTalkRadio11 Okt 2024

Antiviral Drug Development: Overcoming Challenges to the Current Model

As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug development and how NanoViricides developed a nanotechnology with a different approach to develop and deliver antiviral drugs. Anil also presents an overview of the scientific and clinical development of NanoViricides lead program, NV-387 as well as potential applications in different indications. For more information about NanoViricides Incorporated, visit NanoViricides.com. For more information about the annual PODD drug delivery conference, please visit Drug-Delivery.org.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
rss-ronden
kapitalet-en-podd-om-ekonomi
angestpodden
rss-ai-med-jonas-benjamin
rss-mottagningen
medicinvetarna
det-morka-psyket
halsorevolutionen
sexet
rss-vetenskapsradion-2
rss-experimentet
rss-spraket
ufo-sverige
rss-vetenskapsradion
bildningskomplexet
bildningspodden
svd-nyhetsartiklar